A new Nomi Health report found that GLP-1 use and spending among adolescents rose sharply from 2022 to 2025, raising concerns about future costs for self-insured employers.
The post Report: How Employers Can Better Manage GLP-1s for Adolescents appeared first on MedCity News.
